Filing Details

Accession Number:
0001593968-22-000959
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-05-12 17:00:34
Reporting Period:
2022-05-10
Accepted Time:
2022-05-12 17:00:34
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1673772 Rapt Therapeutics Inc. RAPT () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1337831 Kb Rodney Young C/O Rapt Therapeutics, Inc.
561 Eccles Avenue
South San Francisco CA 94080
Chief Financial Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-05-10 5,000 $10.53 10,084 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Includes 5,084 shares acquired by the Reporting Person under the Issuer's 2019 Employee Stock Purchase Plan between 2020 and 2022.